Attached files
| file | filename |
|---|---|
| EX-99.1 - INVESTOR PRESENTATION MARCH 2010 - KINDRED HEALTHCARE, INC | dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 24, 2010
KINDRED HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 001-14057 | 61-1323993 | ||
| (State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
680 South Fourth Street
Louisville, Kentucky
(Address of principal executive offices)
40202-2412
(Zip Code)
Registrant’s telephone number, including area code: (502) 596-7300
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 7.01. | Regulation FD Disclosure. |
Senior members of the management team for Kindred Healthcare, Inc. (the “Company”), including Richard A. Lechleiter, Executive Vice President and Chief Financial Officer, will be making a presentation regarding the Company at the Barclays Capital Global Healthcare Conference in Miami, Florida, on Wednesday, March 24, 2010, at 2:30 p.m. Eastern Time. The presentation is being audio webcast and can be accessed at the Company’s website at http://investors.kindredhealthcare.com. The slides accompanying the presentation are attached to this Current Report on Form 8-K as Exhibit 99.1 and are incorporated solely for the purposes of this Item 7.01 disclosure. These materials will also be available on the Company’s investor relations website at http://investors.kindredhealthcare.com.
The information in this Item 7.01 disclosure, including Exhibit 99.1 attached hereto, is being furnished under Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section. The information in this Item 7.01 disclosure, including Exhibit 99.1 attached hereto, shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
| Item 9.01. | Financial Statements and Exhibits |
| (d) | Exhibits |
| Exhibit 99.1 | Kindred Healthcare, Inc. Investor Presentation March 2010 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.
| Date: March 24, 2010 | By: | /s/ Joseph L. Landenwich | ||||
| Joseph L. Landenwich | ||||||
| Senior Vice President of Corporate Legal Affairs and Corporate Secretary |